I-Noopept (157115-85-0)

Kwangathi 7, 2021

ICofttek ingumkhiqizi omuhle kakhulu we-Noopept e-China. Ifektri yethu inohlelo oluphelele lokuphathwa kokukhiqiza (i-ISO9001 & ISO14001), enekhono lokukhiqiza lenyanga elingu-600kg njalo ngenyanga.

 


Isimo: Ekukhiqizeni kweMisa
Iyunithi: 1kg / isikhwama, 25kg / Drum

I-Noopept (157115-85-0) Siziqu

Igama: I-Noopept
CAS: 157115-85-0
Ukuhlanzeka 98%
Ifomula Yamamolekhula: C17H22N2O4
Isisindo Yamamolekhula: 318.37 g / moll
I-Melt Point: 94.0 kuya ku-98.0 ° C
Igama lamakhemikhali: ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate
omqondofana: I-Noopept; i-ethyl 2 - [[((2S) -1- (2-phenylacetyl) pyrrolidine-2-carbonyl] amino] i-acetate; I-N- (1- (Phenylacetyl) -L-prolyl) i-glycine ethyl ester; i-Ethyl 1- (phenylacetyl ) -L-prolylglycinate; i-noopept powder; I-Nootropic GVS-111; (S) -ethyl 2- (1- (2-phenylacetyl) pyrrolidine-2-carboxaMido) i-acetate; I-SGS 111
InChI Key: I-PJNSMUBMSNAEEN-AWEZNQCLSA-N
Ukuphila okungaphelele: I-noopept half-life yimizuzu engama-60 kuya kwengu-90 nje, okusho ukuthi umuntu ojwayelekile angakwazi ukucubungula ngokugcwele isigamu somthamo kuleso sikhathi.
Umswakama: I-Soluble ku-DMSO (25 mg / ml)
Isimo Sokugcina: 0 - 4 C isikhathi esifushane (izinsuku kuya emavikini), noma -20 C isikhathi eside (izinyanga)
Isicelo: I-Noopept iyisengezo esithandwayo esithuthukisa ukuqonda emphakathini we-nootropic. Izifundo zabantu zikhombise imiphumela ethembisayo, ngokufaka isicelo ekwelashweni kwesifo i-Alzheimer's.
ukubukeka: i-white to beige powder

 

Kuyini I-Noopept (157115-85-0)?

I-Noopept yigama lomkhiqizo le-N-phenylacetyl-L-prolylglycine ethyl ester; inhlanganisela yokwenziwa ye-nootropic evame ukushiwo ngephutha ukuthi iyingxenye yesigaba se-racetam se-nootropics (ayinayo i-2-oxo-pyrollidine nucleus ngakho akuyona i-racetam). ERussia, lapho kwahlanganiswa khona okokuqala iNoopept, kwesinye isikhathi ibizwa nge-GSV-111.

I-Noopept yadalwa ngo-1996. Isakhiwo sayo sisekelwe kulokho kwe-cycloprolylglycine; i-neuropeptide engapheli. ICycloprolylglycine yaziwa ngokukhuthaza ukubonakaliswa kweBrain Derives Neurotrophic Factor ebuchosheni. Ngakho-ke abacwaningi bathi i-nootropic esekwe ku-cycloprolylglycine ingaba nemiphumela efanayo, futhi yilokho kanye okushiwo ngeNoopept.

Yize kungeyona i-racetam, iNoopept ifana nePiracetam. I-Noopept empeleni i-dipeptide conjugate yePiracetam. Ama-molecule amabili kuthiwa anemiphumela efanayo kakhulu, neNoopept iba namandla kakhulu kuma-nootropics amabili ngesisindo.

 

Izinzuzo zeNoopept (157115-85-0)

Izinzuzo ezihambisana neNoopept zibanzi futhi ziyahlukahluka. Lokhu akumangazi ngoba inamandla okubili i-acetylcholine futhi inyusa amazinga we-NGF ne-BDNF.

Nalu uhlu lwezinzuzo ezivame ukuhlotshaniswa neNoopept:

  • Umsebenzi wememori othuthukisiwe
  • Ukunakwa okuthuthukisiwe, ukugxila nokugxila
  • Ukuphaphama okwengeziwe
  • Kukhuthaza i-neuroplasticity nokukhula kwezicubu ezintsha zobuchopho
  • Yehlisa ukucindezeleka kwe-oxidative futhi ikhuthaze impilo yobuchopho
  • Yehlisa ukukhathazeka futhi ikhuthaze ukujabula

Yonke le miphumela ingavela ekwandiseni izinombolo ze-acetylcholine receptor kulwelwesi lwe-neuronal nasekwandiseni amazinga we-NGF / BDNF esikhathini eside. Umphumela ophakamisa i-neuropeptide ekuqondeni mkhulu kakhulu, futhi umphumela wesikhashana esifushane we-acetylcholine onamandla uyabonakala impela. Umphumela ohlangene walezi zinqubo ezimbili empeleni ungaba ukugcwaliseka okuphelele kobuchopho, ngazo zonke izici zokusebenza kobuchopho kuthuthukiswe ngandlela thile.

 

I-Noopept (157115-85-0) isebenzisa?

I-Noopept iyisengezo esithandwayo esithuthukisa ukuqonda emphakathini we-nootropic. I-Noopept isetshenziselwa ikakhulukazi ukukhulisa ukusayinda kwe-acetylcholine, ukukhulisa ukubonakaliswa kwe-BDNF ne-NGF, ukuvikela ubuthi be-glutamate, nokwandisa i-neurotransmission engavimbeleki ebuchosheni. Lezi izindlela ezihlongozwayo zokusebenza ezincike ezifundweni zangaphambi kokuhlinzwa.

 

I-Noopept (157115-85-0) Isikali

Ukulandelwa kwe-Noopept kungadida, ikakhulukazi kwabaqalayo, kepha nangu umhlahlandlela osheshayo futhi olula wokukusiza uphume.

Khumbula, ngenkathi i-Noopept ivame ukuqhathaniswa ne-Piracetam, empeleni ifinyelela izikhathi eziyi-1000 ezinamandla kunePiracetam!

Ngalokho kusho, ungasebenzisi inani elifanayo nobungalisebenzisa ngePiracetam noma ngamanye ama-nootropics anemiphumela efanayo.

Njengomthetho ojwayelekile, kufanele futhi usakaze umthamo owodwa usuku lonke bese uthatha ikhefu njalo ezinyangeni ezimbili ngenhloso yokuphepha.

 

  • I-Oral Dosage

Umthamo onconyelwe umuntu omdala ngu-10-30 mg, kuya ngesisindo sakho. Kodwa-ke, kungcono ngaso sonke isikhathi ukuqala nge-10 mg nje ukuhlola umphumela emzimbeni wakho.

Ngemuva kwakho konke, ungahlala ukhulisa umthamo ngemuva kwalokho.

Ama-capsules eza ngobukhulu obuhlukahlukene, ngakho-ke qiniseka ukuthi uhlola ilebula kahle ngaphambi kokuthenga ibhodlela.

Thatha kuphela inani elincane olidingayo ukuphepha kwakho. Lokhu kuzokusiza futhi ukukuvimbela ekwakheni ukubekezelela umuthi.

 

  • Isilinganiso esilinganayo

Ngomthamo ongezansi, kufanele uqale kancane, cishe ku-5 mg.

Njengoba inemiphumela esheshayo futhi enamandla, kufanele uqaphele ukuthi usabela kanjani kule ndlela ngaphambi kokukhuphukela kumthamo ojwayelekile we-10 mg.

Kubaluleke kakhulu ukukala ngokunembile inani le-powder olidingayo. Ukweqiwa okuphezulu kungaholela emiphumeleni emibi yeNoopept, ngakho-ke qaphela!

 

  • Ukuthwebula Isilinganiso Sama-Powder

Ngokufana nomthamo wezilimi ezingezansi, ukuhogela umthamo we-powder kufanele kube phansi impela.

Ngenkathi kuphephile ukuthatha u-10-30 mg nganoma yiluphi uhlobo, i-Noopept ingadala ikhanda, ukukhathala, nesicanucanu, ngakho-ke hlala uphambuka eceleni kokuqapha.

 

  • I-Megadose

Uma umthamo ojwayelekile ungama-milligram ayi-10 kuye kwangama-30, i-Noopept megadose ingama-milligram angama-50 kuye kwayi-100. Abanye abantu baze bathathe amanani amakhulu kuno-100 mg!

I-megadose isetshenziswa lapho ufuna ukubona ukuthuthuka okuphawulekayo kwimemori yakho, ukufunda, ubuhlakani kanye namakhono wokuqonda jikelele.

Lokhu kufanele kwenziwe kanye ngesonto kakhulu, ngoba ukusetshenziswa okuqhubekayo kungenza kungasebenzi kahle esikhathini eside.

Ngokwengeziwe, lokhu kungaba yingozi enkulu kwabanye abantu, ngakho-ke qiniseka ukuthi uyazi ngokuphelele ngezinga lakho lokubekezela ngaphambi kokuzama lokhu.

 

I-noopept powder ukudayiswa (Ungayitholaphi i-Noopept powder ngobuningi)

Inkampani yethu ithokozela ubudlelwane besikhathi eside namakhasimende ethu ngoba sigxile ekusebenzeni kwamakhasimende nokunikezela ngemikhiqizo emihle. Uma unentshisekelo ngomkhiqizo wethu, siyavumelana nezimo nge-oda eyenziwe ngokwezifiso ukuze ivumelane nesidingo sakho esithile nesikhathi sethu sokuhola esisheshayo kuma-oda siqinisekisa ukuthi uzowunambitha kakhulu umkhiqizo wethu ngesikhathi. Siphinde sigxile nezinsizakalo ezingezwe zenani. Sitholakala ngemibuzo yensiza nolwazi lokuxhasa ibhizinisi lakho.

Singumhlinzeki we-Noopept powder oqeqeshiwe iminyaka eminingana, sihlinzeka ngemikhiqizo ngentengo yokuncintisana, futhi umkhiqizo wethu ungowekhwalithi ephezulu kakhulu futhi uhlolwa ngokuqinile, nokuzimela ukuqinisekisa ukuthi kuphephile ukusetshenziswa emhlabeni jikelele.

 

Okubhekwayo

[1] Ostrovskaya RU, Gudasheva TA, Zaplina AP, Vahitova JV, Salimgareeva MH, Jamidanov RS, Seredenin SB. I-Noopept ivuselela ukubonakaliswa kwe-NGF ne-BDNF ku-hippocampus yamagundane. I-Bull Exp Biol Med. 2008 Septhemba; 146 (3): 334-7. i-doi: 10.1007 / s10517-008-0297-x. I-PMID: 19240853.

[2] I-Neznamov GG, Teleshova ES. Ucwaningo lokuqhathanisa lweNoopept ne-piracetam ekwelapheni iziguli ezinokuphazamiseka okuncane kokuqonda ezifweni zobuchopho eziphilayo zemvelaphi yemithambo nokubi. I-Neurosci Behav Physiol. 2009 Mar; 39 (3): 311-21. i-doi: 10.1007 / s11055-009-9128-4. I-PMID: 19234797.

[3] I-Murzina, i-GB, i-Pivovarov, i-AS Modulation ye-Acetylcholine-Input Input yamanje nguNoopept kuHelix Lucorum Neurons. I-BIOPHYSICS 64, 393-399 (2019).

[4] Neznamov, GG; I-Teleshova, ES (2009). "Ucwaningo lokuqhathanisa lweNoopept ne-piracetam ekwelapheni iziguli ezinokuphazamiseka okuncane kokuqonda kwezifo zobuchopho eziphilayo zemvelaphi yemithambo nokuhlukumezeka". I-Neuroscience nePhysology Yokuziphatha. 39 (3): 311--321.

[5] I-Tardner, P (2020). "Ukuthola isilinganiso esifanelekile se -nootropic agent Noopept: Ukuhlaziywa kwemibhalo etholakalayo" (PDF). Ijenali Yomhlaba Wonke Yesayensi Yezemvelo Nobuchwepheshe.